Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

83.29 -2.17 (-2.54%)
Streaming Delayed Price Updated: 11:51 AM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
Sometimes, a discounted stock can present a valuable opportunity. 
Via The Motley Fool
What the Options Market Tells Us About DexCom
Via Benzinga
DexCom Is Great. Here's Why You Shouldn't Buy It.
Two key uncertainties make the prospect of buying it today riskier than is desirable. 
Via The Motley Fool
Is DexCom a Millionaire Maker?
It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible. 
Via The Motley Fool
NASDAQ:DXCM, a strong growth stock, setting up for a breakout.
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout. 
Via Chartmill
Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks
These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the last two quarters. 
Via The Motley Fool
Topics Artificial Intelligence
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Is DexCom a Millionaire-Maker Stock?
The stock has delivered superior returns in the past 19 years. 
Via The Motley Fool
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
No need to break the bank to get in on these excellent companies. 
Via The Motley Fool
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
The stock isn't normally this cheap, and investors should take advantage. 
Via The Motley Fool
Jim Cramer Doesn't Like Carnival Right Now: Royal Caribbean Is 'The One You Want'
Royal Caribbean has "the best systems right now," Jim Cramer says. "It's got the best numbers. It's the one you want, not Carnival." 
Via Benzinga
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
The companies are now duking it out for a new population of CGM users. 
Via Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $38,000 Today
Via Benzinga
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
Via Chartmill
Decoding 18 Analyst Evaluations For DexCom
Via Benzinga
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo... 
Via Benzinga
Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
The company is upbeat on its upcoming Stelo launch. The CGM is geared to people who don't use insulin. 
Via Investor's Business Daily
Is It Time to Buy July's Worst-Performing S&P 500 Stocks?
These stocks took a dive recently, and that could spell opportunity. 
Via The Motley Fool
Topics Stocks
S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest. 
Via Benzinga
Topics Stocks
S&P 500, Nasdaq Look To Snap Best Win Streaks Of 2024
Stocks are taking a breather, with the S&P 500 Index and Nasdaq Composite Index firmly lower this afternoon after yesterday nabbing their eighth-straight gains and best win streaks of the year. 
Via Talk Markets
Topics Stocks
S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers
Via Benzinga
Topics Stocks
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
These companies' growth paths should only be briefly interrupted by headwinds. 
Via The Motley Fool
2 Growth Stocks to Buy at a Discount
Look beyond share price at the business behind the stock, and you might find there's more for investors to consider. 
Via The Motley Fool
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers
Over the past twelve months, 10 large-cap stocks have underperformed all others. Here’s this week’s list of the top 10 worst performing large-caps. 
Via Talk Markets
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best... 
Via Benzinga
Topics Stocks
1 Growth Stock Down 43% to Buy Right Now
Here's why DexCom should be on your radar after the company's share price plunged recently. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
The tech sector began selling off in July as investors abandoned former higher fliers, leaving these three as the worst Nasdaq 100 stocks. 
Via InvestorPlace
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
DexCom now trades at a drastically lower earnings multiple than it has in the past. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.